Comment on Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients. [J Antimicrob Chemother. 2016]
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings / Cucchetto, Giulia; Lanzafame, Massimiliano; Nicolè, Stefano; Lattuada, Emanuela; Calza, Leonardo; Concia, Ercole. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 72:7(2017), pp. 2138-2140. [10.1093/jac/dkx106]
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings
Lanzafame, Massimiliano;
2017-01-01
Abstract
Comment on Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients. [J Antimicrob Chemother. 2016]File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JAC 2017 cucchetto.pdf
Solo gestori archivio
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
89.62 kB
Formato
Adobe PDF
|
89.62 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione
